In contrast, studies have reported that high expression levels of syndecan-1 in breast carcinoma are associated with high histological grade, high mitotic count, large tumor size, c-erbB-2 over-expression, and estrogen receptor-negative status. This evidence concerns the gene SDC1 and neoplasm.